Drugs / BSI-082
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07086768 | Jan 2026 → Aug 2027 expected | metastatic malignant neoplasm | Lei Zheng | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BSI-082 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07086768 ↗ |
| Route | Intravenous | “as an IV infusion” NCT07086768 ↗ |